Clinical trial
Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
NCT07888894 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Health Dialogues for Individuals With Psychosis Spectrum Disorders
- Lead sponsor
- Uppsala University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- December 1, 2030
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
metabolic syndrome, psychoses
Arms
As registered; 1 arm.
-
Targeted health dialogues
Targeted health dialogues will be implemented utilizing a visual tool, the "Health curve" (Hälsokurvan). The "Health curve" displays the individual health profile, which is derived from participants' responses to three health domains. The domains under investigation encompass Dietary patterns, Levels of physical activity, and aggregated Alcohol and tobacco use, as well as Psychosocial circumstances and Hereditary predispositions to diabetes and cardiovascular diseases. The "Health curve" has three colors, ranging from green to red, with red indicating high risk.
The conversation will be conducted as a person-centred dialogue, focusing on the participant's own motivation and goals for lifestyle changes.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Changes from baseline in Body Mass Index after 12 months
Lead sponsor's other trials
Uppsala University, most recent start first.
+384 more trials See the organization page
Similar trials
Same condition (Psychotic Disorders) and phase, most recent start first.
+760 more trials See the condition page